U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring
May 9, 2022
Written by Biobot Analytics & published on May 9, 2022 by PR Newswire
Cambridge, Mass. – May 3, 2022 – The U.S. Centers for Disease Control (CDC) has selected Biobot Analytics to expand the agency’s National Wastewater Surveillance System (NWSS), an integral part of President Biden’s plan to fight Covid-19 and prepare the country for future pandemics. NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.
The Biden Administration recognizes wastewater monitoring as a predictive indicator of new cases as well as an inclusive public health tool. Dr. Ashish Jha, the White House Covid-19 Response Coordinator, wrote that wastewater monitoring “can give us early insights into rising case rates and help us track infections in the community.”
Over the next year, the CDC will work with Biobot to collect and analyze wastewater samples from 500 communities across the country to gather SARS-CoV-2 data. This builds upon Biobot’s previous work with the U.S. Department of Health and Human Services to make wastewater monitoring accessible to communities in all U.S. states, territories, and tribal nations.
“We’re thrilled that the CDC, with support from Congress and the Administration, recognizes the tremendous value of wastewater monitoring and has expanded the country’s efforts. This program will allow hundreds of local communities to benefit from this novel technology, and we’re proud to be the U.S. government’s trusted partner in this deployment,” said Newsha Ghaeli, Biobot President & Cofounder.
Founded in 2017, Biobot is an MIT research project spin-off. They envision wastewater monitoring as a permanent part of our sewer infrastructure and urban fabric, with wastewater data continuously used to inform inclusive and proactive public health decision-making.
About Biobot Analytics
Biobot Analytics is a global leader in wastewater epidemiology, founded with the goal of transforming wastewater infrastructure into real-time public health observatories. Having worked at more than 700 locations across all 50 US states and several countries, Biobot produces actionable information from wastewater to improve the health of communities around the world. Biobot’s pioneering data platform also supports building-level monitoring for enterprise customers and minimizes business operation disruptions for seamless return-to-office plans.
Learn more about our Government and Enterprise platforms at our website, www.biobot.io/government & www.biobot.io/enterprise. More information on our mission and technology is available at our website, www.biobot.io.